TipRanks
Advertisement
Advertisement
Castle Biosciences approved for dual listing on Nasdaq Texas
PremiumThe FlyCastle Biosciences approved for dual listing on Nasdaq Texas
2M ago
Castle Biosciences Ups 2026 Outlook Amid Growth
Premium
Company Announcements
Castle Biosciences Ups 2026 Outlook Amid Growth
2M ago
Castle Biosciences price target raised to $44 from $40 at BTIG
Premium
The Fly
Castle Biosciences price target raised to $44 from $40 at BTIG
3M ago
Castle Biosciences Lifts 2026 Outlook After Q2 Growth
PremiumCompany AnnouncementsCastle Biosciences Lifts 2026 Outlook After Q2 Growth
3M ago
Castle Biosciences reports Q2 EPS (7c), consensus (41c)
Premium
The Fly
Castle Biosciences reports Q2 EPS (7c), consensus (41c)
3M ago
Castle Biosciences raises 2026 revenue view to $365M-$375M from $345M-$355M
Premium
The Fly
Castle Biosciences raises 2026 revenue view to $365M-$375M from $345M-$355M
3M ago
Castle Biosciences Explores Early Atopic Dermatitis Flare Detection With Home Device Study
PremiumCompany AnnouncementsCastle Biosciences Explores Early Atopic Dermatitis Flare Detection With Home Device Study
4M ago
Castle Biosciences Shareholders Back Board, Governance and Pay
Premium
Company Announcements
Castle Biosciences Shareholders Back Board, Governance and Pay
5M ago
Castle Biosciences price target lowered to $35 from $50 at KeyBanc
Premium
The Fly
Castle Biosciences price target lowered to $35 from $50 at KeyBanc
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―